Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis
Taken together, these data confirm currently recommended linezolid doses for children. The risk of anemia in children should be carefully considered and monitored. Initiating linezolid in children with low baseline hemoglobin increases the probability of experiencing grade 3 or 4 anemia.
Authors
- Hendrik Simon Schaaf (ORCID: https://orcid.org/0000-0001-5755-4133)
- Radojka M. Savić (ORCID: https://orcid.org/0000-0003-3143-5579)
- Jennifer Furin (ORCID: https://orcid.org/0000-0002-0825-7199)
- Belén Pérez Solans (ORCID: https://orcid.org/0000-0003-4621-5480)
- Anneke Catharina Hesseling (ORCID: https://orcid.org/0000-0001-9399-9834)
- Anthony J. Garcia‐Prats (ORCID: https://orcid.org/0000-0002-9280-1950)
- Louvina E. van der Laan (ORCID: https://orcid.org/0000-0002-3584-7477)
- Agathe Béranger (ORCID: https://orcid.org/0000-0002-9751-8249)
- Sangeeta Sharma (ORCID: https://orcid.org/0000-0001-7411-5335)
- Jordan T. Brooks (ORCID: https://orcid.org/0000-0001-9060-9714)
- Heather R. Draper
Institutions
- University of Wisconsin–Madison (US)
- Harvard University (US)
- Desmond Tutu HIV Foundation (ZA)
- University of Cape Town (ZA)
- University of California, San Francisco (US)
- Université Paris Cité (FR)
- Stellenbosch University (ZA)
- Sorbonne Paris Cité (FR)
- LRS Institute of Tuberculosis and Respiratory Diseases (IN)
- Wisconsin Division of Public Health (US)
- Harvard Global Health Institute (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1093/cid/ciae497
- Citations
- 2
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.78